Background Epidermal growth factor receptor (EGFR) gene mutation testing is crucial for the administration of tyrosine kinase inhibitors to treat non–small cell lung cancer. In addition to traditional tissue-based tests, liquid biopsies using plasma are increasingly utilized, particularly for detecting T790M mutations. This study compared tissue- and plasma-based EGFR testing methods.
Methods A total of 248 patients were tested for EGFR mutations using tissue and plasma samples from 2018 to 2023 at Pusan National University Yangsan Hospital. Tissue tests were performed using PANAmutyper, and plasma tests were performed using the Cobas EGFR Mutation Test v2.
Results All 248 patients underwent tissue-based EGFR testing, and 245 (98.8%) showed positive results. Of the 408 plasma tests, 237 (58.1%) were positive. For the T790M mutation, tissue biopsies were performed 87 times in 69 patients, and 30 positive cases (38.6%) were detected. Plasma testing for the T790M mutation was conducted 333 times in 207 patients, yielding 62 positive results (18.6%). Of these, 57 (27.5%) were confirmed to have the mutation via plasma testing. Combined tissue and plasma tests for the T790M mutation were positive in nine patients (13.4%), while 17 (25.4%) were positive in tissue only and 12 (17.9%) in plasma only. This mutation was not detected in 28 patients (43.3%).
Conclusions Although the tissue- and plasma-based tests showed a sensitivity of 37.3% and 32.8%, respectively, combined testing increased the detection rate to 56.7%. Thus, neither test demonstrated superiority, rather, they were complementary.
Background MicroRNAs (miRNA/miR) play significant roles in the regulation of cell differentiation, cell cycle progression, and apoptosis. They become dysregulated during carcinogenesis and are eventually released into the circulation, enabling their detection in body fluids. Thus, this study compared the miRNA expression in tissue and plasma samples of colorectal cancer (CRC) patients and clinically healthy controls and determined miRNA expression as a potential CRC biomarker.
Methods Using quantitative reverse transcription polymerase chain reaction (RT-qPCR), miR-21-5p, miR-29a-3p, miR-92a-3p, miR-135b-5p, miR-196b-5p, and miR-197-3p, expression was analyzed and compared between the malignant (n = 41) and the adjacent neoplasm free mucosal tissues (n = 41) of CRC patients. The findings were validated in plasma samples (n = 36) collected from the same CRC patients prior to surgery or any form of treatment and compared to plasma from their age and sex-matched controls (n = 36).
Results MiR-21-5p, miR-29a-3p, miR-92a-3p, and miR- 196b-5p were upregulated and miR-135b-5p was downregulated in CRC malignant tissues compared to their expression in adjacent neoplasm-free tissue. This was further observed in the plasma of the same CRC cases compared to controls. MiR-92a-3p showed itself the most sensitive (0.93; p < .001) and most specific (0.95; p < .001) in detecting CRC in tissue. In plasma, miR-196b-5p was the most sensitive (0.97; p < .001) and specific (0.94; p < .001) in detecting CRC. Plasma miR-92a-3p and miR-196b-5p were the most sensitive (0.95; p < .001) and specific (0.94; p < .001) in the early detection of CRC.
Conclusions Results show that specific miRNAs dysregulated in malignant
tissues are released and can be detected in the circulation, supporting their potential as non-invasive biomarkers of CRC.
Citations
Citations to this article as recorded by
miR-135b: A key role in cancer biology and therapeutic targets Yingchun Shao, Shuangshuang Zhang, Yuxin Pan, Zhan Peng, Yinying Dong Non-coding RNA Research.2025; 12: 67. CrossRef
The role of tumor-associated fibroblast-derived exosomes in chemotherapy resistance of colorectal cancer and its application prospect Meichen Liu, Teng-zheng Li, Cheng-ming Peng Biochimica et Biophysica Acta (BBA) - General Subjects.2025; : 130796. CrossRef
Except for Robust Outliers, Rapamycin Increases Lesion Burden in a Murine Model of Cerebral Cavernous Malformations Roberto J. Alcazar-Felix, Robert Shenkar, Christian R. Benavides, Akash Bindal, Abhinav Srinath, Ying Li, Serena Kinkade, Tatiana Terranova, Evon DeBose-Scarlett, Rhonda Lightle, Dorothy DeBiasse, Hanadi Almazroue, Diana Vera Cruz, Sharbel Romanos, Aditya Translational Stroke Research.2024;[Epub] CrossRef
Identification of miRNAs Present in Cell- and Plasma-Derived Extracellular Vesicles—Possible Biomarkers of Colorectal Cancer Marzena Lenart, Izabela Siemińska, Rafał Szatanek, Anna Mordel, Antoni Szczepanik, Mateusz Rubinkiewicz, Maciej Siedlar, Monika Baj-Krzyworzeka Cancers.2024; 16(13): 2464. CrossRef
The emerging role of blood-based biomarkers in early detection of colorectal cancer: A systematic review Faris Shweikeh, Yuhao Zeng, Abdur Rahman Jabir, Erica Whittenberger, Saurav P. Kadatane, Yuting Huang, Mohamad Mouchli, Dani Ran Castillo Cancer Treatment and Research Communications.2024; 42: 100872. CrossRef
The Role of Extracellular Vesicles in Colorectal Cancer Yujian Xia, Chaoran Yu, Ernest Johann Helwig, Yousheng Li Technology in Cancer Research & Treatment.2023;[Epub] CrossRef
HNRNPA2B1-Mediated MicroRNA-92a Upregulation and Section Acts as a Promising Noninvasive Diagnostic Biomarker in Colorectal Cancer Yiling Li, Kexin Li, Xiaoying Lou, Yue Wu, Samuel Seery, Danfei Xu, Yuqing Pei, Benheng Qian, Yuxin Wu, Shuang Liang, Kui Wu, Wei Cui Cancers.2023; 15(4): 1367. CrossRef
Role of salivary miRNAs in the diagnosis of gastrointestinal disorders: a mini-review of available evidence Maria Oana Săsăran, Claudia Bănescu Frontiers in Genetics.2023;[Epub] CrossRef
Exploring the Role of Circulating Cell-Free RNA in the Development of Colorectal Cancer Chau-Ming Kan, Xiao Meng Pei, Martin Ho Yin Yeung, Nana Jin, Simon Siu Man Ng, Hin Fung Tsang, William Chi Shing Cho, Aldrin Kay-Yuen Yim, Allen Chi-Shing Yu, Sze Chuen Cesar Wong International Journal of Molecular Sciences.2023; 24(13): 11026. CrossRef
Lynch Syndrome Biopathology and Treatment: The Potential Role of microRNAs in Clinical Practice Serena Ascrizzi, Grazia Maria Arillotta, Katia Grillone, Giulio Caridà, Stefania Signorelli, Asad Ali, Caterina Romeo, Pierfrancesco Tassone, Pierosandro Tagliaferri Cancers.2023; 15(15): 3930. CrossRef
Blood liquid biopsy has emerged as a way of overcoming the clinical limitations of repeat biopsy by testing for the presence of acquired resistance mutations to therapeutic agents. Despite its merits of repeatability and non-invasiveness, this method is currently only used as a supplemental test due to a relatively low sensitivity rate of 50%–60%, and cannot replace tissue biopsy. The circulating tumor DNAs used in blood liquid biopsies are passive products of fragmented DNA with a short half-life released following tumor cell death; the low sensitivity seen with liquid blood biopsy results from this instability, which makes increasing the sensitivity of this test fundamentally difficult. Extracellular vesicles (EVs) are ideal carriers of cancer biomarkers, as cancer cells secret an abundance of EVs, and the contents of tumor cell-originated EVs reflect the molecular and genetic composition of parental cells. In addition, EV-derived DNAs (EV DNAs) consist of large-sized genomic DNAs and tumor-specific oncogenic mutant DNAs. For these reasons, liquid biopsy using EV DNA has the potential to overcome issues arising from tissue shortages associated with small biopsies, which are often seen in lung cancer patients, and the biopsy product can be used in other diagnostic methods, such as epidermal growth factor receptor (EGFR) mutation testing and next-generation sequencing (NGS). A higher sensitivity can be achieved when EV DNAs obtained from bronchoalveolar lavage fluid (BALF) are used rather than those from blood. BALF, when obtained close to the tumor site, is a promising liquid biopsy tool, as it enables the gathering of both cellular and non-cellular fractions of the tumor microenvironment, and provides increased diagnostic sensitivity when compared to blood.
Citations
Citations to this article as recorded by
Circulating Extracellular Vesicles as Promising Biomarkers for Precession Diagnostics: A Perspective on Lung Cancer Sunil Vasu, Vinith Johnson, Archana M, K. Anki Reddy, Uday Kumar Sukumar ACS Biomaterials Science & Engineering.2025; 11(1): 95. CrossRef
Diagnostic performance of metagenomic next-generation sequencing among hematological malignancy patients with bloodstream infections after antimicrobial therapy Yueyi Xu, Miaoxin Peng, Tong Zhou, Yonggong Yang, Peipei Xu, Ting Xie, Xuefang Cao, Bing Chen, Jian Ouyang Journal of Infection.2025; 90(2): 106395. CrossRef
Nanobiotechnology: A smart platform of the future transform liquid biopsy era Srijan Goswami, Palas Samanta, Manab Deb Adhikari The Journal of Liquid Biopsy.2024; 3: 100137. CrossRef
Mesenchymal stem/stromal cells: dedicator to maintain tumor homeostasis Juncun Yao, Li Sun, Feng Gao, Wei Zhu Human Cell.2024;[Epub] CrossRef
Extracellular Vesicle-DNA: The Next Liquid Biopsy Biomarker for Early Cancer Diagnosis? Irène Tatischeff Cancers.2023; 15(5): 1456. CrossRef
Isolation of extracellular vesicles from human plasma samples: The importance of controls Migmar Tsamchoe, Stephanie Petrillo, Anthoula Lazaris, Peter Metrakos Biotechnology Journal.2023;[Epub] CrossRef
The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation in the field Sive Mullen, Dania Movia European Journal of Pharmaceutical Sciences.2023; 188: 106516. CrossRef
Silicon microfabrication technologies for biology integrated advance devices and interfaces Vuslat B. Juska, Graeme Maxwell, Pedro Estrela, Martyn E. Pemble, Alan O'Riordan Biosensors and Bioelectronics.2023; 237: 115503. CrossRef
Bronchoalveolar Lavage as Potential Diagnostic Specimens to Genetic Testing in Advanced Nonsmall Cell Lung Cancer Xuwen Lin, Yazhou Cai, Chenyu Zong, Binbin Chen, Di Shao, Hao Cui, Zheng Li, Ping Xu Technology in Cancer Research & Treatment.2023;[Epub] CrossRef
In-Cell Labeling Coupled to Direct Analysis of Extracellular Vesicles in the Conditioned Medium to Study Extracellular Vesicles Secretion with Minimum Sample Processing and Particle Loss Anissa Viveiros, Vaibhavi Kadam, John Monyror, Luis Carlos Morales, Desmond Pink, Aja M. Rieger, Simonetta Sipione, Elena Posse de Chaves Cells.2022; 11(3): 351. CrossRef
Recent advances in liquid biopsy in cancers: Diagnosis, disease state and treatment response monitoring Zhixian Chen, Judy Wai Ping Yam Clinical and Translational Discovery.2022;[Epub] CrossRef
Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment Cristina Catoni, Veronica Di Paolo, Elisabetta Rossi, Luigi Quintieri, Rita Zamarchi Diagnostics.2021; 11(6): 1118. CrossRef
DNA-Loaded Extracellular Vesicles in Liquid Biopsy: Tiny Players With Big Potential? Susana García-Silva, Miguel Gallardo, Héctor Peinado Frontiers in Cell and Developmental Biology.2021;[Epub] CrossRef
Characteristics and Clinical Application of Extracellular Vesicle-Derived DNA Jae Young Hur, Kye Young Lee Cancers.2021; 13(15): 3827. CrossRef
Bronchoalveolar Lavage as a Potential Diagnostic Specimens to Genetic Testing in Advanced Lung Cancer Xuwen Lin, Xueying Wang, Yazhou Cai, Chenyu Zong, Dawei Liu, Jiming Yu, Chenxin Zhou, Jing Yao, Zheng Li, ping xu SSRN Electronic Journal .2021;[Epub] CrossRef
Multi-Omics Data Integration in Extracellular Vesicle Biology—Utopia or Future Reality? Leona Chitoiu, Alexandra Dobranici, Mihaela Gherghiceanu, Sorina Dinescu, Marieta Costache International Journal of Molecular Sciences.2020; 21(22): 8550. CrossRef
With advances in target therapy, molecular analysis of tumors is routinely required for treatment decisions in patients with advanced non-small cell lung cancer (NSCLC). Liquid biopsy refers to the sampling and analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blood. Because the technique is minimally invasive, liquid biopsies are the future in cancer management. Epidermal growth factor receptor (EGFR) ctDNA tests have been performed in routine clinical practice in advanced NSCLC patients to guide tyrosine kinase inhibitor treatment. In the near future, liquid biopsy will be a crucial prognostic, predictive, and diagnostic method in NSCLC. Here we present the current status and future perspectives of liquid biopsy in NSCLC.
Citations
Citations to this article as recorded by
Comparison of tissue-based and plasma-based testing for EGFR mutation in non–small cell lung cancer patients Yoon Kyung Kang, Dong Hoon Shin, Joon Young Park, Chung Su Hwang, Hyun Jung Lee, Jung Hee Lee, Jee Yeon Kim, JooYoung Na Journal of Pathology and Translational Medicine.2025; 59(1): 60. CrossRef
Lab-in-a-Fiber detection and capture of cells João C. Varela, Achar V. Harish, Pawel Maniewski, Timothy Gibbon, Oana Tudoran, Rainer Heuchel, Matthias Löhr, Walter Margulis, Aman Russom, Fredrik Laurell Scientific Reports.2025;[Epub] CrossRef
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer Chiara Reina, Berina Šabanović, Chiara Lazzari, Vanesa Gregorc, Christopher Heeschen Translational Research.2024; 272: 41. CrossRef
Tailored point-of-care biosensors for liquid biopsy in the field of oncology Sima Singh, Pritam Saha Podder, Matt Russo, Charles Henry, Stefano Cinti Lab on a Chip.2023; 23(1): 44. CrossRef
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer Akash Bararia, Prosenjeet Chakraborty, Paromita Roy, Bitan Kumar Chattopadhay, Amlan Das, Aniruddha Chatterjee, Nilabja Sikdar World Journal of Gastroenterology.2023; 29(15): 2241. CrossRef
Liquid biopsy in the management of advanced lung cancer: Implementation and practical aspects Gabriela Fernandes, Ana Rodrigues, Cláudia Matos, Fernando Barata, Luís Cirnes, Lurdes Ferreira, José Albino Lopes, Margarida Felizardo, Paula Fidalgo, Ulisses Brito, Bárbara Parente Cancer Treatment and Research Communications.2023; 36: 100725. CrossRef
Tweezer PCR: A Highly Specific Method for Accurate Identification of Low-Abundance Mutations Shanglin Li, Yin Gu, Zhi Geng, Kaiyi Li, Yawei Hu, Qiang Liu, Rongxin Fu, Peng Liu Analytical Chemistry.2023; 95(48): 17679. CrossRef
Mesonephric-like Adenocarcinoma of the Ovary: Clinicopathological and Molecular Characteristics Hyun Hee Koh, Eunhyang Park, Hyun-Soo Kim Diagnostics.2022; 12(2): 326. CrossRef
Alveolar Soft Part Sarcoma of the Uterus: Clinicopathological and Molecular Characteristics Yurimi Lee, Kiyong Na, Ha Young Woo, Hyun-Soo Kim Diagnostics.2022; 12(5): 1102. CrossRef
Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines Sora Kim, Gwang Ha Kim, Su Jin Park, Chae Hwa Kwon, Hoseok I, Moon Won Lee, Bong Eun Lee Journal of Clinical Medicine.2022; 11(15): 4426. CrossRef
Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee Journal of Pathology and Translational Medicine.2021; 55(3): 181. CrossRef
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer Pamela Abdayem, David Planchard European Respiratory Review.2021; 30(161): 200294. CrossRef
Dynamics of Specific cfDNA Fragments in the Plasma of Full Marathon Participants Takehito Sugasawa, Shin-ichiro Fujita, Tomoaki Kuji, Noriyo Ishibashi, Kenshirou Tamai, Yasushi Kawakami, Kazuhiro Takekoshi Genes.2021; 12(5): 676. CrossRef
Future Perspectives in Detecting EGFR and ALK Gene Alterations in Liquid Biopsies of Patients with NSCLC Daniela Ferreira, Juliana Miranda, Paula Martins-Lopes, Filomena Adega, Raquel Chaves International Journal of Molecular Sciences.2021; 22(8): 3815. CrossRef
Real-World Analysis of the EGFR Mutation Test in Tissue and Plasma Samples from Non-Small Cell Lung Cancer Hyunwoo Lee, Joungho Han, Yoon-La Choi Diagnostics.2021; 11(9): 1695. CrossRef
Objective Quantitation of EGFR Protein Levels using Quantitative Dot Blot Method for the Prognosis of Gastric Cancer Patients Lei Xin, Fangrong Tang, Bo Song, Maozhou Yang, Jiandi Zhang Journal of Gastric Cancer.2021; 21(4): 335. CrossRef
The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer D. Akhoundova, J. Mosquera Martinez, L. E. Musmann, C. Britschgi, C. Rütsche, M. Rechsteiner, E. Nadal, M. R. Garcia Campelo, A. Curioni-Fontecedro Journal of Clinical Medicine.2020; 9(11): 3674. CrossRef
Expanding opportunities in precision oncology T Raja Cancer Research, Statistics, and Treatment.2020; 3(4): 863. CrossRef
Dong Hoon Shin, Hyo Sup Shim, Tae Jung Kim, Heae Surng Park, Yun La Choi, Wan Seop Kim, Lucia Kim, Sun Hee Chang, Joon Seon Song, Hyo jin Kim, Jung Ho Han, Chang Hun Lee, Geon Kook Lee, Se Jin Jang
J Pathol Transl Med. 2019;53(3):153-158. Published online February 28, 2019
Liquid biopsy for detection of mutation from circulating tumor DNA is a new technology which is attractive in that it is non-invasive. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) is an effective first line drug for advanced non-small cell lung cancer patients who harbor activating EGFR mutation. During the course of treatment, resistance against TKI arises which can be contributed to EGFR T790M mutation in about 50–60% of patients. Third generation TKI may overcome the resistance. In patients who cannot undergo tissue biopsy due to variable reasons, liquid biopsy is an excellent alternative for the detection of EGFR T790M mutation. However, this relatively novel method requires standardization and vigorous quality insurance. Thus, a standard set of guideline recommendations for liquid biopsy for EGFR mutation testing suitable for the Korean medical community is necessary. In this article, we propose a set of provisional guideline recommendations that was discussed and approved by the Cardiopulmonary Pathology Study Group of the Korean Society of Pathologists.
Citations
Citations to this article as recorded by
Comparison of tissue-based and plasma-based testing for EGFR mutation in non–small cell lung cancer patients Yoon Kyung Kang, Dong Hoon Shin, Joon Young Park, Chung Su Hwang, Hyun Jung Lee, Jung Hee Lee, Jee Yeon Kim, JooYoung Na Journal of Pathology and Translational Medicine.2025; 59(1): 60. CrossRef
Improving non-small-cell lung cancer survival through molecular characterization: Perspective of a multidisciplinary expert panel M.G.O. Fernandes, A.S. Vilariça, B. Fernandes, C. Camacho, C. Saraiva, F. Estevinho, H. Novais e Bastos, J.M. Lopes, P. Fidalgo, P. Garrido, S. Alves, S. Silva, T. Sequeira, F. Barata Pulmonology.2024; 30(1): 4. CrossRef
Unlocking the future of cancer diagnosis – promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer Chiara Reina, Berina Šabanović, Chiara Lazzari, Vanesa Gregorc, Christopher Heeschen Translational Research.2024; 272: 41. CrossRef
Exosomes in Lung Cancer: Actors and Heralds of Tumor Development Amaia Sandúa, Estibaliz Alegre, Álvaro González Cancers.2021; 13(17): 4330. CrossRef
Molecular biomarker testing for non–small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group Sunhee Chang, Hyo Sup Shim, Tae Jung Kim, Yoon-La Choi, Wan Seop Kim, Dong Hoon Shin, Lucia Kim, Heae Surng Park, Geon Kook Lee, Chang Hun Lee Journal of Pathology and Translational Medicine.2021; 55(3): 181. CrossRef
Current status and future perspectives of liquid biopsy in non-small cell lung cancer Sunhee Chang, Jae Young Hur, Yoon-La Choi, Chang Hun Lee, Wan Seop Kim Journal of Pathology and Translational Medicine.2020; 54(3): 204. CrossRef
Prevalence of T790M mutation among TKI-therapy resistant Lebanese lung cancer patients based on liquid biopsy analysis: a first report from a major tertiary care center Hazem Assi, Arafat Tfayli, Nada Assaf, Sarah Abou Daya, Aram H. Bidikian, Dima Kawsarani, Puzant Fermanian, Ghazi Zaatari, Rami Mahfouz Molecular Biology Reports.2019; 46(4): 3671. CrossRef
The rapid and accurate diagnosis of patients with minimally invasive procedures was once only found in science fiction. However, the discovery of extracellular vesicles (EVs) and their near ubiquity in body fluids, coupled with the advent of inexpensive next generation sequencing techniques and EV purification protocols, promises to make science fiction a reality. Purifying and sequencing the RNA content of EV from routine blood draws and urine samples are likely to enable pathologists and physicians to diagnose and track the progress of diseases in many inaccessible tissues in the near future. Here we present the evolutionary background of EV, summarize the biology of EV formation and cargo selection, and discuss the current barriers to making continuous liquid biopsies through the use of EV a science reality.
Citations
Citations to this article as recorded by
Blood-derived APLP1
+
extracellular vesicles are potential biomarkers for the early diagnosis of brain diseases
Yuri Choi, Jae Hyun Park, Ala Jo, Chul-Woo Lim, Ji-Min Park, Jin Woo Hwang, Kang Soo Lee, Young-Sang Kim, Hakho Lee, Jisook Moon Science Advances.2025;[Epub] CrossRef
The Role of Nanotechnology in Understanding the Pathophysiology of Traumatic Brain Injury Saranya Selvaraj, Laksiri Weerasinghe Central Nervous System Agents in Medicinal Chemistry.2025; 25(1): 20. CrossRef
Extracellular Vesicles as Delivery Vehicles for Non-Coding RNAs: Potential Biomarkers for Chronic Liver Diseases Arianna Ferro, Gabriele Saccu, Simone Mattivi, Andrea Gaido, Maria Beatriz Herrera Sanchez, Shafiul Haque, Lorenzo Silengo, Fiorella Altruda, Marilena Durazzo, Sharmila Fagoonee Biomolecules.2024; 14(3): 277. CrossRef
From understanding to action: Exploring molecular connections of Down syndrome to Alzheimer's disease for targeted therapeutic approach Sonal Sukreet, Michael S. Rafii, Robert A. Rissman Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring.2024;[Epub] CrossRef
Extracellular vesicles and cancer stem cells: a deadly duo in tumor progression Akram Tayanloo-Beik, Azin Eslami, Masoumeh Sarvari, Hasan Jalaeikhoo, Mohsen Rajaeinejad, Mohsen Nikandish, Ali Faridfar, Mostafa Rezaei-Tavirani, Ahmad Rezazadeh Mafi, Bagher Larijani, Babak Arjmand Oncology Reviews.2024;[Epub] CrossRef
Tumor-Derived Extracellular Vesicles as Liquid Biopsy for Diagnosis and Prognosis of Solid Tumors: Their Clinical Utility and Reliability as Tumor Biomarkers Prerna Dabral, Nobel Bhasin, Manish Ranjan, Maysoon M. Makhlouf, Zakaria Y. Abd Elmageed Cancers.2024; 16(13): 2462. CrossRef
miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma Jenni Karttunen, Lajos Kalmar, Andrew Grant, Jun Ying, Sarah E. Stewart, Xiaonan Wang, Fiona Karet Frankl, Tim Williams Scientific Reports.2024;[Epub] CrossRef
Urine Extracellular Vesicles Size Subsets as Lupus Nephritis Biomarkers Itze C. Navarro-Hernandez, Raúl F. Reyes-Huerta, Mariana Cañez-Hernández, Jiram Torres-Ruiz, Daniel A. Carrillo-Vázquez, Laura P. Whittall-García, David E. Meza-Sánchez, Guillermo Juárez-Vega, Diana Gómez-Martin, José M. Hernández-Hernández, José L. Marav Diagnostics.2024; 14(20): 2271. CrossRef
Emerging insights in senescence: pathways from preclinical models to therapeutic innovations Luke Mansfield, Valentina Ramponi, Kavya Gupta, Thomas Stevenson, Abraham Binoy Mathew, Agian Jeffilano Barinda, Florencia Herbstein, Samir Morsli npj Aging.2024;[Epub] CrossRef
Autologous Platelet and Extracellular Vesicle-Rich Plasma as Therapeutic Fluid: A Review Kaja Troha, Domen Vozel, Matevž Arko, Apolonija Bedina Zavec, Drago Dolinar, Matej Hočevar, Zala Jan, Matic Kisovec, Boštjan Kocjančič, Ljubiša Pađen, Manca Pajnič, Samo Penič, Anna Romolo, Neža Repar, Vesna Spasovski, Nejc Steiner, Vid Šuštar, Aleš Iglič International Journal of Molecular Sciences.2023; 24(4): 3420. CrossRef
Liquid Biopsies, Novel Approaches and Future Directions Athanasios Armakolas, Maria Kotsari, John Koskinas Cancers.2023; 15(5): 1579. CrossRef
Proteomic Signature of Extracellular Vesicles Associated with Colorectal Cancer Natalia Soloveva, Svetlana Novikova, Tatiana Farafonova, Olga Tikhonova, Victor Zgoda Molecules.2023; 28(10): 4227. CrossRef
Engineering extracellular vesicles for Alzheimer's disease: An emerging cell‐free approach for earlier diagnosis and treatment Sabrina Valentina Lazar, Sirjan Mor, David Wang, Leora Goldbloom‐Helzner, Kaitlin Clark, Dake Hao, Diana Lee Farmer, Aijun Wang WIREs Mechanisms of Disease.2022;[Epub] CrossRef
Engineered exosomes as a natural nanoplatform for cancer targeted delivery of metal-based drugs Tao Feng, Johannes Karges, Xinxing Liao, Liangnian Ji, Hui Chao Coordination Chemistry Reviews.2022; 454: 214325. CrossRef
Storage conditions determine the characteristics of red blood cell derived extracellular vesicles Tímea Bebesi, Diána Kitka, Anikó Gaál, Imola Csilla Szigyártó, Róbert Deák, Tamás Beke-Somfai, Kitti Koprivanacz, Tünde Juhász, Attila Bóta, Zoltán Varga, Judith Mihály Scientific Reports.2022;[Epub] CrossRef
Novel Exosome Biomarker Candidates for Alzheimer’s Disease Unravelled Through Mass Spectrometry Analysis Tânia Soares Martins, Rui Marçalo, Cristóvão B. da Cruz e Silva, Dário Trindade, José Catita, Francisco Amado, Tânia Melo, Ilka Martins Rosa, Jonathan Vogelgsang, Jens Wiltfang, Odete A. B. da Cruz e Silva, Ana Gabriela Henriques Molecular Neurobiology.2022; 59(5): 2838. CrossRef
Saliva Based Liquid Biopsies in Head and Neck Cancer: How Far Are We From the Clinic? Aditi Patel, Shanaya Patel, Parina Patel, Vivek Tanavde Frontiers in Oncology.2022;[Epub] CrossRef
Incidental Detection of Maternal Malignancy by Fetal Cell-Free DNA Screening Britton D. Rink, Blair K. Stevens, Mary E. Norton Obstetrics & Gynecology.2022;[Epub] CrossRef
Investigating the consistency of extracellular vesicle production from breast cancer subtypes using CELLine adherent bioreactors Colin L. Hisey, Anastasiia Artuyants, George Guo, Vanessa Chang, Gabrielle Reshef, Martin Middleditch, Bincy Jacob, Lawrence W. Chamley, Cherie Blenkiron Journal of Extracellular Biology.2022;[Epub] CrossRef
Diagnostic and therapeutic potential of exosomes in Alzheimer’s disease Tânia Soares Martins, Dário Trindade, Margarida Vaz, Inês Campelo, Martim Almeida, Guilherme Trigo, Odete A. B. da Cruz e Silva, Ana Gabriela Henriques Journal of Neurochemistry.2021; 156(2): 162. CrossRef
Composition of the whole transcriptome in the human plasma: Cellular source and modification by aging Tapio Nevalainen, Arttu Autio, Maija Puhka, Marja Jylhä, Mikko Hurme Experimental Gerontology.2021; 143: 111119. CrossRef
Extracellular vesicles in cancer diagnostics and therapeutics Adeeb Shehzad, Salman Ul Islam, Raheem Shahzad, Salman Khan, Young Sup Lee Pharmacology & Therapeutics.2021; 223: 107806. CrossRef
Elevated complement mediator levels in endothelial-derived plasma exosomes implicate endothelial innate inflammation in diminished brain function of aging humans Fanny M. Elahi, Danielle Harvey, Marie Altendahl, Nivetha Brathaban, Nicole Fernandes, Kaitlin B. Casaletto, Adam M. Staffaroni, Pauline Maillard, Jason D. Hinman, Bruce L. Miller, Charles DeCarli, Joel H. Kramer, Edward J. Goetzl Scientific Reports.2021;[Epub] CrossRef
Extracellular Vesicles as Mediators of Cancer Disease and as Nanosystems in Theranostic Applications Renato Burgos-Ravanal, América Campos, Magda C. Díaz-Vesga, María Fernanda González, Daniela León, Lorena Lobos-González, Lisette Leyton, Marcelo J. Kogan, Andrew F. G. Quest Cancers.2021; 13(13): 3324. CrossRef
Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical Applications Maria Chiara Ciferri, Rodolfo Quarto, Roberta Tasso Biology.2021; 10(5): 359. CrossRef
A multiparametric extraction method for Vn96-isolated plasma extracellular vesicles and cell-free DNA that enables multi-omic profiling Jeremy W. Roy, Catherine A. Taylor, Annie P. Beauregard, Surendar R. Dhadi, D. Craig Ayre, Sheena Fry, Simi Chacko, Gabriel Wajnberg, Andrew P. Joy, Ngoc-Nu Mai-Thi, Nicolas Crapoulet, David A. Barnett, Anirban Ghosh, Stephen M. Lewis, Rodney J. Ouellette Scientific Reports.2021;[Epub] CrossRef
The distinct roles of exosomes in tumor-stroma crosstalk within gastric tumor microenvironment Hanyu Zhang, Min Yang, Xu Wu, Qianxiu Li, Xin Li, Yueshui Zhao, Fukuan Du, Yu Chen, Zhigui Wu, Zhangang Xiao, Jing Shen, Qinglian Wen, Wei Hu, Chi Hin Cho, Meijuan Chen, Yejiang Zhou, Mingxing Li Pharmacological Research.2021; 171: 105785. CrossRef
Exosomes in Alzheimer’s Disease: From Being Pathological Players to Potential Diagnostics and Therapeutics Hagar M. Soliman, Ghada A. Ghonaim, Shaza M. Gharib, Hitesh Chopra, Aya K. Farag, Mohamed H. Hassanin, Abdalrazeq Nagah, Mahmoud Emad-Eldin, Nevertary E. Hashem, Galal Yahya, Sherif E. Emam, Abdalla E. A. Hassan, Mohamed S. Attia International Journal of Molecular Sciences.2021; 22(19): 10794. CrossRef
Mitochondrial Quality Control in Cardiac-Conditioning Strategies against Ischemia-Reperfusion Injury Wylly Ramsés García-Niño, Cecilia Zazueta, Mabel Buelna-Chontal, Alejandro Silva-Palacios Life.2021; 11(11): 1123. CrossRef
Proteomic Profiling of Exosomes Derived from Plasma of HIV-Infected Alcohol Drinkers and Cigarette Smokers Sunitha Kodidela, Yujie Wang, Benjamin J. Patters, Yuqing Gong, Namita Sinha, Sabina Ranjit, Kelli Gerth, Sanjana Haque, Theodore Cory, Carole McArthur, Anil Kumar, Jim Y. Wan, Santosh Kumar Journal of Neuroimmune Pharmacology.2020; 15(3): 501. CrossRef
Promising Applications of AIEgens in Animal Models Bairong He, Bo Situ, Zujin Zhao, Lei Zheng Small Methods.2020;[Epub] CrossRef
Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes Tine Tesovnik, Jernej Kovač, Katka Pohar, Samo Hudoklin, Klemen Dovč, Nataša Bratina, Katarina Trebušak Podkrajšek, Maruša Debeljak, Peter Veranič, Emanuele Bosi, Lorenzo Piemonti, Alojz Ihan, Tadej Battelino Frontiers in Cell and Developmental Biology.2020;[Epub] CrossRef
The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance Cristina P. R. Xavier, Hugo R. Caires, Mélanie A. G. Barbosa, Rui Bergantim, José E. Guimarães, M. Helena Vasconcelos Cells.2020; 9(5): 1141. CrossRef
Connexin-46 Contained in Extracellular Vesicles Enhance Malignancy Features in Breast Cancer Cells Rodrigo A. Acuña, Manuel Varas-Godoy, Viviana M. Berthoud, Ivan E. Alfaro, Mauricio A. Retamal Biomolecules.2020; 10(5): 676. CrossRef
Mentalexo approach for diagnosis of psychiatric disorders Ahmet Topuzoğlu, Can Ilgın Medical Hypotheses.2020; 143: 109823. CrossRef
Reagent-free total protein quantification of intact extracellular vesicles by attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy Veronika Szentirmai, András Wacha, Csaba Németh, Diána Kitka, Anita Rácz, Károly Héberger, Judith Mihály, Zoltán Varga Analytical and Bioanalytical Chemistry.2020; 412(19): 4619. CrossRef
Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles Manuel Castanheira de Oliveira, Hugo R. Caires, Maria J. Oliveira, Avelino Fraga, M. Helena Vasconcelos, Ricardo Ribeiro Cancers.2020; 12(6): 1400. CrossRef
(Sub)populations of extracellular vesicles released by TNF‐α –triggered human endothelial cells promote vascular inflammation and monocyte migration Baharak Hosseinkhani, Nynke M.S. van den Akker, Daniel G.M. Molin, Luc Michiels Journal of Extracellular Vesicles.2020;[Epub] CrossRef
Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma In Ae Kim, Jae Young Hur, Hee Joung Kim, Seung Eun Lee, Wan Seop Kim, Kye Young Lee Journal of Pathology and Translational Medicine.2020; 54(6): 453. CrossRef
Mitochondrial RNA in Alzheimer’s Disease Circulating Extracellular Vesicles Kyoung Mi Kim, Qiong Meng, Olivia Perez de Acha, Maja Mustapic, Aiwu Cheng, Erden Eren, Gautam Kundu, Yulan Piao, Rachel Munk, William H. Wood, Supriyo De, Ji Heon Noh, Michael Delannoy, Lesley Cheng, Kotb Abdelmohsen, Dimitrios Kapogiannis, Myriam Gorosp Frontiers in Cell and Developmental Biology.2020;[Epub] CrossRef
Challenges in Biomaterial-Based Drug Delivery Approach for the Treatment of Neurodegenerative Diseases: Opportunities for Extracellular Vesicles Asit Kumar, Lina Zhou, Kaining Zhi, Babatunde Raji, Shelby Pernell, Erene Tadrous, Sunitha Kodidela, Anantha Nookala, Harry Kochat, Santosh Kumar International Journal of Molecular Sciences.2020; 22(1): 138. CrossRef
Tumor-specific genetic aberrations in cell-free DNA of gastroesophageal cancer patients Kristina Magaard Koldby, Michael Bau Mortensen, Sönke Detlefsen, Per Pfeiffer, Mads Thomassen, Torben A. Kruse Journal of Gastroenterology.2019; 54(2): 108. CrossRef
Raman tweezers microspectroscopy of circa 100 nm extracellular vesicles Sergei G. Kruglik, Félix Royo, Jean-Michel Guigner, Laura Palomo, Olivier Seksek, Pierre-Yves Turpin, Irène Tatischeff, Juan M. Falcón-Pérez Nanoscale.2019; 11(4): 1661. CrossRef
Application of Extracellular Vesicles Proteomics to Cardiovascular Disease: Guidelines, Data Analysis, and Future Perspectives Maria N. Barrachina, Beatriz Calderón‐Cruz, Lucía Fernandez‐Rocca, Ángel García PROTEOMICS.2019;[Epub] CrossRef
Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung Hyun Min Koh, Hyo Jung An, Gyung Hyuck Ko, Jeong Hee Lee, Jong Sil Lee, Dong Chul Kim, Jung Wook Yang, Min Hye Kim, Sung Hwan Kim, Kyung Nyeo Jeon, Gyeong-Won Lee, Se Min Jang, Dae Hyun Song Journal of Pathology and Translational Medicine.2019; 53(1): 13. CrossRef
High-fidelity probing of the structure and heterogeneity of extracellular vesicles by resonance-enhanced atomic force microscopy infrared spectroscopy Sally Yunsun Kim, Dipesh Khanal, Bill Kalionis, Wojciech Chrzanowski Nature Protocols.2019; 14(2): 576. CrossRef
Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy Trends in Pharmacological Sciences.2019; 40(3): 172. CrossRef
Intercellular Vesicular Transfer by Exosomes, Microparticles and Oncosomes - Implications for Cancer Biology and Treatments Ritu Jaiswal, Lisa M. Sedger Frontiers in Oncology.2019;[Epub] CrossRef
Dictyostelium: A Model for Studying the Extracellular Vesicle Messengers Involved in Human Health and Disease Irène Tatischeff Cells.2019; 8(3): 225. CrossRef
Extracellular Vesicles as Diagnostics and Therapeutics for Structural Epilepsies Jenni Karttunen, Mette Heiskanen, Anssi Lipponen, David Poulsen, Asla Pitkänen International Journal of Molecular Sciences.2019; 20(6): 1259. CrossRef
Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs Hiroshi Ageta, Kunihiro Tsuchida Cellular and Molecular Life Sciences.2019; 76(24): 4829. CrossRef
Exosome release and cargo in Down syndrome Eric D. Hamlett, Angela LaRosa, Elliott J. Mufson, Juan Fortea, Aurélie Ledreux, Ann‐Charlotte Granholm Developmental Neurobiology.2019; 79(7): 639. CrossRef
Exosomes in specific fractions of the boar ejaculate contain CD44: A marker for epididymosomes? Manuel Alvarez-Rodriguez, Stefan A. Ljunggren, Helen Karlsson, Heriberto Rodriguez-Martinez Theriogenology.2019; 140: 143. CrossRef
A review on protein markers of exosome from different bio-resources and the antibodies used for characterization Fengyan Deng, Josh Miller Journal of Histotechnology.2019; 42(4): 226. CrossRef
Tangential Flow Microfluidics for the Capture and Release of Nanoparticles and Extracellular Vesicles on Conventional and Ultrathin Membranes Mehdi Dehghani, Kilean Lucas, Jonathan Flax, James McGrath, Thomas Gaborski Advanced Materials Technologies.2019;[Epub] CrossRef
Lipidomic analysis of urinary exosomes from hereditary α‐tryptasemia patients and healthy volunteers Sarah C. Glover, Mohammad‐Zaman Nouri, Kubra M. Tuna, Lybil B. Mendoza Alvarez, Lisa K. Ryan, James F. Shirley, Ying Tang, Nancy D. Denslow, Abdel A. Alli FASEB BioAdvances.2019; 1(10): 624. CrossRef
Novel Epigenetic Biomarkers in Pregnancy-Related Disorders and Cancers Valentina Karin-Kujundzic, Ida Marija Sola, Nina Predavec, Anamarija Potkonjak, Ema Somen, Pavao Mioc, Alan Serman, Semir Vranic, Ljiljana Serman Cells.2019; 8(11): 1459. CrossRef
The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer Emne A. Abdallah, Alexcia C. Braun, Bianca C.T.C.P. Flores, Laís Senda, Ana Cláudia Urvanegia, Vinicius Calsavara, Victor Hugo Fonseca de Jesus, Maria Fernanda Arruda Almeida, Maria Dirlei Begnami, Felipe J.F. Coimbra, Wilson Luiz da Costa, Diana Noronha The Oncologist.2019; 24(9): e854. CrossRef
Role of tumor‑derived extracellular vesicles in cancer progression and their clinical applications (Review) Fuhao Qiao, Peng Pan, Jiaping Yan, Jing Sun, Yan Zong, Zhiyong Wu, Xiaoqin Lu, Na Chen, Rui Mi, Yongbin Ma, Yuan Ji International Journal of Oncology.2019;[Epub] CrossRef
Circulating tumor DNA – Current state of play and future perspectives Gabriele De Rubis, Sabna Rajeev Krishnan, Mary Bebawy Pharmacological Research.2018; 136: 35. CrossRef
“Liquid Biopsy” of White Matter Hyperintensity in Functionally Normal Elders Fanny M. Elahi, Kaitlin B. Casaletto, Marie Altendahl, Adam M. Staffaroni, Evan Fletcher, Teresa J. Filshtein, Maria M. Glymour, Bruce L. Miller, Jason D. Hinman, Charles DeCarli, Edward J. Goetzl, Joel H. Kramer Frontiers in Aging Neuroscience.2018;[Epub] CrossRef
The role of exosomal transport of viral agents in persistent HIV pathogenesis Benjamin J. Patters, Santosh Kumar Retrovirology.2018;[Epub] CrossRef